This inventor holds 1 USPTO granted patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Carol Zhao
Introduction
Carol Zhao is an accomplished inventor based in Titusville, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of pulmonary arterial hypertension. Her innovative approach has led to the development of methods that enhance patient care and treatment outcomes.
Latest Patents
One of Carol Zhao's notable patents is titled "Transitioning patients treated for pulmonary arterial hypertension to selexipag." This patent outlines methods for transitioning patients who are currently being treated with a non-selexipag prostacyclin pathway agent (PPA) to selexipag. This advancement is crucial for improving the management of pulmonary arterial hypertension and demonstrates her commitment to enhancing patient health.
Career Highlights
Carol Zhao is associated with Actelion Pharmaceuticals Ltd, a company known for its focus on innovative treatments for pulmonary diseases. Her work at Actelion has positioned her as a key player in the pharmaceutical industry, contributing to groundbreaking research and development.
Collaborations
Throughout her career, Carol has collaborated with esteemed colleagues such as Wade Benton and Gary Arnold Palmer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Carol Zhao's contributions to the field of pulmonary arterial hypertension treatment exemplify her dedication to improving patient outcomes through innovation. Her patent and work at Actelion Pharmaceuticals Ltd highlight her role as a leading inventor in the medical field.